Biocept Teams Up with Protean BioDiagnostics to Study Target Selector in Determining EGFR Mutations in Tumor Samples Andrew Kessel for Proactive InvestorsFebruary 23rd, 2021 Read More Anthony MaglioccoFebruary 23, 2021Andrew Kessel, Proactive Investors